Figure 3From: New targeted molecular therapies for cancer: radiological response in intrathoracic malignancies and cardiopulmonary toxicity: what the radiologist needs to know68 year old male with metastatic thyroid cancer. CT scan with contrast (Figure A) shows hyper vascular mediastinal nodes (arrow) consistent with metastatic disease. CT scan obtained after 2 cycles of Gefitinib (Figure B) demonstrates decrease in the attenuation of mediastinal nodes (arrow) reflecting desvascularization, with a thin rim of residual peripheral enhancement.Back to article page